Initiation of Antiseizure Medications in Patients With Brain Abscess

Are antiseizure medications (ASMs) associated with a reduced risk of epilepsy in brain abscess survivors at 90, 135, and 180 days of follow-up?In this cohort study of 572 patients with a brain abscess, there were no statistically significant differences in the probabilities of epilepsy occurrence at 90, 135, and 180 days after initiation of ASMs.The findings suggest that the initiation of ASMs was not associated with reduced epilepsy risk in patients with brain abscess.

Corresponding Author: Victoria M. Nielsen, MPH, Department of Public Health and Health Sciences, Northeastern University, 360 Huntington Ave, Boston, MA 02115 (v.nielsen@northeastern.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.